Author of the publication

The prevention and treatment of missing data in clinical trials: an FDA perspective on the importance of dealing with it.

, and . Clinical pharmacology and therapeutics, 91 (3): 550-4 (March 2012)Dades censurades; RCT; Regulació; Imputació múltiple; LOCF.
DOI: 10.1038/clpt.2011.340

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Drug-Review Deadlines and Safety Problems, , , and . The New England Journal of Medicine, 359 (1): 95 (2008)Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues, and . Annals of Internal Medicine, 133 (6): 455-463 (2000)3311<m:linebreak></m:linebreak>Intervenció/placebo.The prevention and treatment of missing data in clinical trials: an FDA perspective on the importance of dealing with it., and . Clinical pharmacology and therapeutics, 91 (3): 550-4 (March 2012)Dades censurades; RCT; Regulació; Imputació múltiple; LOCF.Effects of tibialis anterior muscle vibration on quiet stance., , and . HAPTICS, page 523-528. IEEE, (2014)Coercive-sexting: Predicting adolescent initial exposure to electronic coercive sexual dating violence., , , , , and . Comput. Hum. Behav., (April 2023)Generalizations that aren't?: Evidence on education and growth. European Economic Review, 45 (4-6): 905--918 (May 2001)